ROXALL Group is an international pharmaceutical company based in Hamburg, Germany. Our core business is pharmaceuticals for allergen immunotherapy – the only causal allergy therapy renowned by the World Health Organization (WHO) that not only has the capacity to prevent an allergy turning into asthma but can also block the growth of new sensitizations. At ROXALL, we strive to constantly improve our treatments and to manufacture the highest quality products. As a result, we have made several and many of the most important innovations in this field. ROXALL Group has subsidiaries in Europe, Asia and Latin America. The acquisition of the allergy-line of a pharmaceutical company in Bilbao, Spain, opened us a solid basis for future growth. Research in immuno- therapy has been the main focus of this company for more than 70 years. Our team in Bilbao works closely with leading research institutes, providing us with greater potential for developing new treatments. In addition to our allergen immune therapies, our subsidiary company DR. BECKMANN Pharma offers medical products that help ease many allergy symptoms. Our products range from nasal showers and ointments for sensitive skin to high quality allergen encasings and peak-flow meters.
View Top Employees from ROXALL GroupWebsite | http://roxall.com |
Revenue | $1 million |
Employees | 102 (4 on RocketReach) |
Address | 20 Meessen, Oststeinbek, Schleswig-Holstein 22113, DE |
Phone | +49 40 8972520 |
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Retail |
SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular ROXALL Group employee's phone or email?
The ROXALL Group annual revenue was $1 million in 2024.
4 people are employed at ROXALL Group.
ROXALL Group is based in Oststeinbek, Schleswig-Holstein.
The NAICS codes for ROXALL Group are [32541, 3254, 325, 32].
The SIC codes for ROXALL Group are [28, 283, 2834].